x

Search for a clinical trial

* (*) mandatory field

54 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member = ; Member of a ERN =

National clinical trial(s)

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
MSC: Treatment of Refractory Severe Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells - (Phase I-II) - FR
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité de Médecine interne, Maladies Auto-immunes et Pathologie Vasculaire

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Recruiting trial
Ongoing trial
SCLERADEC III : SCLERoderma and Adipose-DErived Stroma Cells (Phase II)
CHU de Marseille - Hôpital Nord
Service de Médecine Interne

ITALY

TOSCANA
FIRENZE

Ongoing trial
Randomized Controlled Trial for Testing the Efficacy of Well-Being Therapy in Patients With Systemic Sclerosis
Università degli studi di Firenze
Dipartimento di Scienze della Salute

NETHERLANDS

Utrecht
UTRECHT

BELGIUM

OOST-VLAANDEREN
GENT

Recruiting trial
Ongoing trial
NOVESA studie: GLPG1690 in de behandeling van vroegtijdige diffuse systeemsclerose - BE
Ghent University Hospital - UZ Gent
Department of Rheumatology

GERMANY

Baden-Württemberg
TÜBINGEN

Recruiting trial
Ongoing trial
AST-MOMA: Highdose Chemotherapy and transplantation of CD34 selected stem cell for progressive systemic sclerosis - Modification according to manifestation (Phase II)
Interdisziplinäres Rheumazentrum (INDIRA)
Zentrum für Interdisziplinäre Rheumatologie, klinische Immunologie und Autoimmunerkrankungen

GERMANY

Bayern
ERLANGEN

Ongoing trial
RESOLVE-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis -DE-
Internistisches Zentrum des Universitätsklinikums Erlangen
Medizinische Klinik 3 - Rheumatologie und Immunologie

GERMANY

Berlin
BERLIN

Ongoing trial
RESOLVE-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis -DE-
Charité - Universitätsmedizin Berlin (CCM)
Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie

ITALY

MARCHE
ANCONA

Recruiting trial
Ongoing trial
High dose intravenous N-Acetylcysteine vs Iloprost for Early, rapidly progressive diffuse systemic Sclerosis
Università Politecnica delle Marche - Polo Didattico
Istituto di Clinica Medica

ITALY

MARCHE
ANCONA

Ongoing trial
Low-dose oral Imatinib in the treatment of Scleroderma pulmonary involvement: a phase II pilot sutdy
Università Politecnica delle Marche - Polo Didattico
Istituto di Clinica Medica

UNITED KINGDOM

Derbyshire
CHESTERFIELD

UNITED KINGDOM

Greater London
LONDON

UNITED KINGDOM

Greater London
LONDON

Ongoing trial
RESOLVE-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis-GB
University College London Medical School and Royal Free Hospital
Metabolic Bone Disease - Centre for Rheumatology and Connective Tissue Diseases

Multinational clinical trial(s)